Topics:

Rheumatology Network

Thumbs Up for Hyaluronic Acid Injections?

The latest assessment of the controversial injections for knee osteoarthritis deems them effective, and even superior to acetaminophen. What can you believe? An expert on osteoarthritis weighs in..

Recent Content

All of the signs pointed to osteomyelitis with sepsis. But further examination pointed to consequences of poorly controlled gout.

The new SLICC 2012 classification criteria are far more sensitive in real-life clinical practice than the ACR97 lupus criteria, especially within the first 5 years of onset.

A new online journal club, RheumJC, launches with two live chats on Twitter on January 29. It's the first journal club ever in rheumatology, an opportunity for rheumatologists worldwide to discuss important published research.

amyopathic dermatomyositis

Pulmonary embolism and deep vein thrombosis developed in a 40-year-old man with amyopathic dermatomyositis. D-dimer levels were a red flag.

The US Food and Drug Administration (FDA) has approved the interleukin 17A inhibitor secukinumab (Cosentyx) for adults with moderate to severe plaque psoriasis.  

The FDA has decided will not regulate health apps designed to collect disease information. They're not ready to be useful for rheumatology. Nonetheless, your patients are undoubtedly using them.

A recent study confirms an increased risk for type 2 diabetes among gout patients. Quiz yourself here on related comorbidities in gout.

By clicking Accept, you agree to become a member of the UBM Medica Community.